Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Allele-specific therapy for huntington disease haplotypes

Allele-specific therapy for huntington disease haplotypes

US Patent 10533172 · Granted Jan 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Low dose pridopidine for Parkinson's Disease and other diseases associated with 2025
Use of pridopidine for treating rett syndrome2024
Pridopidine for treating drug induced dyskinesias2024
Use of pridopidine for treating dystonias2023
Use of pridopidine to improve cognitive function and for treating Alzheimer's di2022
Method of treating amyotrophic lateral sclerosis with pridopidine2022
Use of pridopidine for the treatment of fragile X syndrome2022
Use of pridopidine for treating functional decline2021
Pridopidine for treating drug induced dyskinesias2021
Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis 2020
Allele-specific therapy for Huntington disease haplotypes2020
Allele-specific therapy for Huntington disease haplotypes2020